Targeting Cancer & Senescence Associated HERVs With mRNA & Adenovirus Encoded Antigens
Time: 12:30 pm
day: Day Two
Details:
- Discussing human endogenous retroviruses (HERVs) as emerged as possible immunotherapeutic targets for cancer and cell senescence associated diseases
- Reviewing how HERVOLUTION have developed mRNA and viral vector delivered HERV antigens forming HERV-like-particles within transduced cells
- Examining unique immunostimulatory mutations and viral chimerism allows effective break of immunological tolerance and anti-cancer and senolytic efficacy
